‡a
Author's Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials.
‡a
Author's More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials
‡a
tocilizumabforseverecovid19pneumoniacaseseriesof5australianpatients
‡A
Tocilizumab for severe COVID-19 pneumonia: Case series of 5 Australian patients
‡9
1
‡a
useofdirectoralanticoagulantsfortreatmentofatrialfibrillationinpatientswithhivareview
‡A
Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV: a review.
‡9
1
‡a
estimatingscenariosforsurvivaltimeinmenstartingsystemictherapiesforcastrationresistantprostatecancerasystematicreviewofrandomisedtrials
‡A
Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials.
‡9
1
‡a
morethanjustthemediancalculatingsurvivaltimesforpatientswithher2positivemetastaticbreastcancerusingdatafromrecentrandomisedtrials
‡A
More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials
‡9
1